Inhibition of the RAF-MEK-ERK cascade was found to increase the dependence of pancreatic ductal adenocarcinoma on autophagy, thereby enhancing its responsiveness to autophagy inhibitors, suggesting a new treatment approach [56]. This evidence concerns the gene MAP2K7 and pancreatic ductal adenocarcinoma.